Clinical Trial Update: Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

View source ↗

Summary

A clinical trial update describes a cross-sectional study evaluating the association of HsCAR with metabolic dysfunction-associated fatty liver disease (MAFLD) …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis
• Liver Fibrosis
• Metabolic Dysfunction-associated Fatty Liver Disease

Snippet

Sponsor: Chongqing Medical University | Conditions: Metabolic Dysfunction-associated Fatty Liver Disease, Hepatic Steatosis | Status: RECRUITING